Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: Analysis of a defined population

Acta Dermato-Venereologica

Volumn 93, Issue 4, 2013, Pages 417-421

  Roozeboom, Marieke H ^a   Lohman, Bjorn G P M Lohman ^a   Westers Attema, Annet ^a   Nelemans, Patty J ^b   Botterweck, Anita A ^c   Van Marion, Arienne M W ^a,d   Kelleners Smeets, Nicole W J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Department of Registration and Research   (Netherlands)

^d VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

Risk factors; Skin cancer

Indexed keywords

AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS FREE SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SKIN CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 84879703185     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1501     Document Type: Article

References (30)

1. Stern RS. The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol 1999; 135: 843-844
2. de Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005; 152: 481-488
3. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998; 78: 144-148
4. Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997; 133: 735-740
5. Veness MJ. Advanced non melanoma skin cancers of the head and neck: an overview on management. Cancer Forum 2006; 30: 195-201
6. Ramirez CC, Federman DG, Kirsner RS. Skin cancer as an occupational disease: the effect of ultraviolet and other forms of radiation. Int J Dermatol 2005; 44: 95-100
7. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El- Naggar AK, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005; 23: 759-765
8. Petter G, Haustein UF. Squamous cell carcinoma of the skin - histopathological features and their significance for the clinical outcome. J Eur Acad Dermatol Venereol 1998; 11: 37-44
9. Mourouzis C, Boynton A, Grant J, Umar T, Wilson A, Macpheson D, et al. Cutaneous head and neck SCCs and risk of nodal metastasis - UK experience. J Craniomaxillofac Surg 2009; 37: 443-447
10. Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007; 33: 885-899
11. Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9: 713-720
12. Eroglu A, Berberoglu U, Berreroglu S. Risk factors related to locoregional recurrence in squamous cell carcinoma of the skin. J Surg Oncol 1996; 61: 124-130
13. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26: 976-990
14. Ch'ng S, Maitra A, Lea R, Brasch H, Tan ST. Parotid metastasis - an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg 2006; 59: 1288-1293
15. Quaedvlieg PJ, Creytens DH, Epping GG, Peutz-Kootstra CJ, Nieman FH, Thissen MR, et al. Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips. Histopathology 2006; 49: 256-264
16. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002; 28: 268-273
17. Dinehart SM, Peterson S. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. Dermatol Surg 2005; 31: 1379-1384
18. Veness MJ. High-risk cutaneous squamous cell carcinoma of the head and neck. J Biomed Biotechnol 2007: 80572
19. Jensen V, Prasad AR, Smith A, Raju M, Wendel CS, Schmelz M, et al. Prognostic criteria for squamous cell cancer of the skin. J Surg Res 2009; 159: 509-516
20. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, 7th edn. Carcinoma of skin. Wiley-Blackwell 2009; 165-168
21. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. J Cutaneous Pathol 2006; 33: 191-206
22. Oosterhuis JW, Coebergh JW, van Veen EB. Tumour banks: well-guarded treasures in the interest of patients. Nature Reviews Cancer 2003; 3: 73-77
23. Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face - results of a retrospective study and review of the literature. Br J Dermatol 2004; 151: 141-147
24. Veness MJ. Defining patients with high-risk cutaneous squamous cell carcinoma. Australas J Dermatol 2006; 47: 28-33
25. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002; 146: 18-25
26. Kundel HL, Polansky M. Measurement of observer agreement. Radiology 2003; 228: 303-308
27. Mullen JT, Feng L, Xing Y, Mansfield PF, Gershenwald JE, Lee JE, et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 2006; 13: 902-909
28. Kyrgidis A, Tzellos TG, Kechagias N, Patrikidou A, Xirou P, Kitikidou K, et al. Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence- free survival. Eur J Cancer 2010; 46: 1563-1572
29. Oddone N, Morgan GJ, Palme CE, Perera L, Shannon J, Wong E, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009; 115: 1883-1891
30. Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm MC, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011; 64: 1051-1059.